Overview

Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

Status:
Not yet recruiting
Trial end date:
2028-06-20
Target enrollment:
Participant gender:
Summary
Bacterial sexually transmitted infections (STIs) have been steadily increasing in gay, bisexual, and other men who have sex with men (MSM) over the past 2 decades. While that trend started prior to the introduction of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) in 2012, HIV PrEP has been associated with increases in sexual contacts and decreases in condom use with an resultant acceleration in the increase of bacterial STIs such as gonorrhea, syphilis, and chlamydia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tanta University
Collaborator:
Marwa Ahmed El-Samongy
Treatments:
Doxycycline
Nitazoxanide
Pentoxifylline